- 专利标题： Novel compounds and compositions as cathepsin inhibitors
-
申请号： US10719080申请日： 2003-11-21
-
公开(公告)号： US20040142999A1公开(公告)日： 2004-07-22
- 发明人: Michael Graupe , Jiayao Li , John Link , Sheila Zipfel , Andreas Paul Timm , David John Aldous , Sukathini Thurairatnam
- 申请人： Aventis Pharmaceuticals Inc. , Axys Pharmaceuticals, Inc.
- 申请人地址： US NJ Bridgewater CA South San Francisco
- 专利权人： Aventis Pharmaceuticals Inc.,Axys Pharmaceuticals, Inc.
- 当前专利权人： Aventis Pharmaceuticals Inc.,Axys Pharmaceuticals, Inc.
- 当前专利权人地址： US NJ Bridgewater CA South San Francisco
- 主分类号： A61K031/40
- IPC分类号： A61K031/40
摘要：
The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
信息查询
